Journal
EMERGING INFECTIOUS DISEASES
Volume 13, Issue 4, Pages 608-610Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1304.061063
Keywords
-
Categories
Ask authors/readers for more resources
In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available